The Cancer Biomarkers market was valued at USD 13.24 Billion in 2022 and is expected to reach USD 36.74 Billion by 2030, growing at a CAGR of 13.6% (2022-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.